Torres-Estay Verónica, Carreño Daniela V, San Francisco Ignacio F, Sotomayor Paula, Godoy Alejandro S, Smith Gary J
Departamento de FisiologíaUrologíaPontificia Universidad Católica de Chile, Santiago de Chile, ChileCenter for Integrative Medicine and Innovative SciencesUniversidad Andrés Bello, Santiago de Chile, ChileDepartment of UrologyRoswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263, USA.
Departamento de FisiologíaUrologíaPontificia Universidad Católica de Chile, Santiago de Chile, ChileCenter for Integrative Medicine and Innovative SciencesUniversidad Andrés Bello, Santiago de Chile, ChileDepartment of UrologyRoswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263, USA Departamento de FisiologíaUrologíaPontificia Universidad Católica de Chile, Santiago de Chile, ChileCenter for Integrative Medicine and Innovative SciencesUniversidad Andrés Bello, Santiago de Chile, ChileDepartment of UrologyRoswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263, USA
J Endocrinol. 2015 Mar;224(3):R131-7. doi: 10.1530/JOE-14-0611. Epub 2015 Jan 6.
Androgen receptor (AR) is a ligand-inducible transcription factor, and a member of the steroid-thyroid-retinoid receptor superfamily, that mediates the biological effects of androgens in a wide range of physiological and pathological processes. AR expression was identified in vascular cells nearly 20 years ago, and recent research has shown that AR mediates a variety of actions of androgens in endothelial and vascular smooth muscle cells. In this mini-review, we review evidence indicating the importance of AR in human endothelial cell (HUVEC) homeostatic and pathogenic processes. Although a role for AR in the modulation of HUVEC biology is evident, the molecular mechanisms by which AR regulates HUVEC homeostasis and disease processes are not fully understood. Understanding these mechanisms could provide critical insights into the processes of pathogenesis of diseases ranging from cardiovascular disease to cancer that are major causes of human morbidity and mortality.
雄激素受体(AR)是一种配体诱导型转录因子,属于类固醇-甲状腺-视黄酸受体超家族,它在广泛的生理和病理过程中介导雄激素的生物学效应。近20年前在血管细胞中发现了AR的表达,最近的研究表明,AR在内皮细胞和血管平滑肌细胞中介导雄激素的多种作用。在本综述中,我们回顾了表明AR在人内皮细胞(HUVEC)稳态和致病过程中重要性的证据。尽管AR在调节HUVEC生物学方面的作用是明显的,但AR调节HUVEC稳态和疾病过程的分子机制尚未完全了解。了解这些机制可能为从心血管疾病到癌症等人类发病和死亡的主要原因的疾病发病机制提供关键见解。